Lifecome Biochemistry Co's Total Assets for the quarter that ended in Mar. 2024 was ¥1,953.5 Mil.
Warning Sign:
If a company builds assets at 29.8% a year, faster than its revenue growth rate of 7.2% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Lifecome Biochemistry Co's average Total Assets Growth Rate was 69.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 34.20% per year.
During the past 5 years, the average Total Assets Growth Rate was 29.80% per year.
During the past 10 years, the average Total Assets Growth Rate was 17.20% per year.
During the past 12 years, Lifecome Biochemistry Co's highest 3-Year average Total Assets Growth Rate was 37.30%. The lowest was -2.90%. And the median was 18.90%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Lifecome Biochemistry Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifecome Biochemistry Co (SZSE:002868) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Lifecome Biochemistry Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Lifecome Biochemistry Co Total Assets Related Terms
Thank you for viewing the detailed overview of Lifecome Biochemistry Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Lifecome Biochemistry Co (SZSE:002868) Business Description
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002868 has been successfully added to your 